Literature DB >> 8916820

Double-blind, randomized comparison of ondansetron and intraoperative propofol to prevent postoperative nausea and vomiting.

T J Gan1, B Ginsberg, A P Grant, P S Glass.   

Abstract

BACKGROUND: Breast surgery is associated with a high incidence of postoperative nausea and vomiting. Propofol and prophylactic administration of ondansetron are associated with a lower incidence of postoperative nausea and vomiting. To date no comparison of these two drugs has been reported. A randomized study was done to compare the efficacy of ondansetron and intraoperative propofol given in various regimens.
METHODS: Study participants included 89 women classified as American Society of Anesthesiologists physical status 1 or 2 who were scheduled for major breast surgery. Patients were randomly assigned to one of four groups. Group O received 4 mg ondansetron in 10 ml 0.9% saline and groups PI, PIP, and PP received 10 ml 0.9% saline before anesthesia induction. Group O received thiopental, isoflurane, nitrous oxide-oxygen, and fentanyl for anesthesia. Group PI received propofol, isoflurane, nitrous oxide-oxygen, and fentanyl. Group PIP received propofol, isoflurane, nitrous oxide-oxygen, and fentanyl. Thirty minutes before expected skin closure, isoflurane was discontinued and 50 to 150 micrograms.kg-1.min-1 propofol was given intravenously to maintain anesthesia. Group PP received propofol for induction and maintenance of anesthesia, nitrous oxide-oxygen, and fentanyl. Postoperative pain relief was provided with morphine administered by a patient-controlled analgesia pump. The incidence of nausea and vomiting, requests for rescue antiemetic and sedation, pain scores, and hemodynamic data were recorded for 24 h.
RESULTS: Within 6 h of surgery, groups O and PP had a lower incidence of nausea compared with groups PI and PIP (P < 0.05). Fewer patients in group PP (19%) vomited during the 24-h period compared with groups O (48%), PI (64%), and PIP (52%) (P < 0.05). The incidence of antiemetic use was also less in group PP (P < 0.05). Patients in group PP had lower sedation scores at 30 min and at 1 h (P < 0.05). There were no differences among the groups in pain scores, blood pressure, heart rate, respiratory rate, and incidence of pruritus.
CONCLUSIONS: Propofol administered to induce and maintain anesthesia is more effective than ondansetron (with thiopental-isoflurane anesthesia) in preventing postoperative vomiting and is associated with fewer requests for rescue antiemetic and sedation in the early phase of recovery. It is equally effective in preventing postoperative nausea as ondansetron in the first 6 h after operation. Propofol used only as an induction agent or for induction and at the end of surgery were not as protective against postoperative nausea and vomiting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916820     DOI: 10.1097/00000542-199611000-00011

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  21 in total

1.  Vomiting after a pediatric adenotonsillectomy: comparison between propofol induced sevoflurane-nitrous oxide maintained anesthesia and TIVA with propofol-remifentanil.

Authors:  Ji-Hyun Chung; Yoon-Hee Kim; Young-Kwon Ko; Sun-Yeul Lee; Yoon-Tae Nam; Seok-Hwa Yoon
Journal:  Korean J Anesthesiol       Date:  2010-09-20

2.  Postoperative nausea and vomiting after endoscopic thyroidectomy: total intravenous vs. balanced anesthesia.

Authors:  Gunn Hee Kim; Hyun Joo Ahn; Hyun-Soo Kim; Si Ra Bang; Hyun-Sung Cho; Mikyung Yang; Jie Ae Kim
Journal:  Korean J Anesthesiol       Date:  2011-06-17

3.  Omission of fentanyl during sevoflurane anesthesia decreases the incidences of postoperative nausea and vomiting and accelerates postanesthesia recovery in major breast cancer surgery.

Authors:  Gotaro Shirakami; Yuriko Teratani; Hajime Segawa; Shogo Matsuura; Tsutomu Shichino; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 4.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Prevention and treatment of postoperative nausea and vomiting.

Authors:  A L Kovac
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

6.  The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Authors:  Sachin Patel; Eric R Wohlfeil; David J Rademacher; Erica J Carrier; LaToya J Perry; Abhijit Kundu; J R Falck; Kasem Nithipatikom; William B Campbell; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

7.  The Wide-Awake Approach to Dupuytren's Disease: Fasciectomy under Local Anesthetic with Epinephrine.

Authors:  Rebecca Nelson; Amanda Higgins; Joanie Conrad; Mike Bell; Don Lalonde
Journal:  Hand (N Y)       Date:  2009-11-10

8.  Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.

Authors:  Yong-Hun Lee; Jae-Hyeon Seo; Kyung-Tae Min; Young-Jin Lim; Seong-Wook Jeong; Eun-Kyung Lee; Byung-Moon Choi; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2016-06-08       Impact factor: 4.335

9.  Optimization of anesthesia antiemetic measures versus combination therapy using dexamethasone or ondansetron for the prevention of postoperative nausea and vomiting.

Authors:  Subhi M Alghanem; Islam M Massad; Ehsan M Rashed; Hamdi M Abu-Ali; Salam S Daradkeh
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

10.  A korean predictive model for postoperative nausea and vomiting.

Authors:  Duck Hwan Choi; Justin Sang Ko; Hyun Joo Ahn; Jie Ae Kim
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.